Observational Trial With Enbrel

CompletedOBSERVATIONAL
Enrollment

4,945

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Rheumatoid Arthritis
Interventions
DRUG

etanercept

The patients will be treated in accordance with the requirements of the labelling of Enbrel® in Germany. The dosage and duration of therapy is to be determined by the physician to meet the patients' individual needs for treatment.

Trial Locations (1)

48149

Pfizer Investigational Site, Münster

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY